These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 6237843)

  • 21. Effects of buflomedil hydrochloride in occlusive arterial disease of the lower limbs stage IV.
    Briguglio F; Briguglio E; Di Marco V; Swat M; Materia G; Intilisano A
    J Int Med Res; 1986; 14(3):115-23. PubMed ID: 3721052
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Multicenter study on the therapeutic activity of buflomedil chlorhydrate in obliterative arteriopathies of the legs].
    Allegra C; Andreozzi GM; Avellone G; Cospite M; Del Guercio R; Lepore R; Nuzzaci G; Pinto A; Romeo S
    Clin Ter; 1986 Oct; 119(1):25-33. PubMed ID: 3539466
    [No Abstract]   [Full Text] [Related]  

  • 23. [Digital blood flow in peripheral vascular diseases. Action of drugs: buflomedil].
    Frausini G; Rotatori P; Gaggi S; Barone A; Pupita F
    Minerva Cardioangiol; 1988 Jun; 36(6):319-22. PubMed ID: 3211330
    [No Abstract]   [Full Text] [Related]  

  • 24. [Conservative treatment of peripheral arterial occlusive diseases].
    Hoffmann J
    Fortschr Med; 1978 Sep; 96(34):1735-8. PubMed ID: 101431
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Clinical trial of a new vasoactive drug F.I. 6714 administered intra-arterially in peripheral vascular diseases].
    Masini G
    Minerva Cardioangiol; 1975 Feb; 23(2):120-5. PubMed ID: 1095956
    [No Abstract]   [Full Text] [Related]  

  • 26. Positive effect of oral buflomedil on exercise-induced haemorheological damage and on claudication distance in peripheral obliterative arterial disease patients.
    Forconi S; Pieragalli D; Acciavatti A; Del Bigo C; Galigani C; Ralli L; Guerrini M; Di Perri T
    J Int Med Res; 1984; 12(3):188-92. PubMed ID: 6734922
    [No Abstract]   [Full Text] [Related]  

  • 27. [Flowmetric, thermometric and rheologic studies in obliterating arterial diseases of the lower extremities treated with buflomedil].
    Dorigo B; Raspanti D; Trapani M; Albanese B; Cameli AM; Digiesi V
    Minerva Med; 1985 Feb; 76(7):269-75. PubMed ID: 3974940
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Therapeutic effect of a combination of bufenine and beta-escine as an oral delayed-action drug in obliterating arterial diseases of the lower limbs].
    Petruzzellis V; Scardigno A; Coviello C
    Minerva Med; 1982 Feb; 73(5):181-6. PubMed ID: 7038552
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Platelet aggregation inhibitory therapy in chronic arterial occlusive disease of the lower limbs: results of short-term clinico-instrumental study with indobufen].
    Landini G; Poggiali C; Calacoci S; Marino N; Rosselli A
    Recenti Prog Med; 1989 Apr; 80(4):204-7. PubMed ID: 2762658
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Experiences with Trental in peripheral circulatory disorders and cerebrovascular insufficiency (author's transl)].
    Schafé MK
    Munch Med Wochenschr; 1973 Oct; 115(40):1745-9. PubMed ID: 4801042
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of buflomedil in a group of patients with chronic peripheral arterial diseases. Clinical and hemorheological evaluation.
    Mozzi E; Chiurazzi D; Spinola A; Annoni F; Germiniani R
    J Int Med Res; 1985; 13(6):317-21. PubMed ID: 4076530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A new surgical approach to vasodilating therapy in peripheral occlusive vascular disease.
    Horch R; Krönung G
    Nihon Geka Hokan; 1988 Nov; 57(6):487-92. PubMed ID: 3268061
    [No Abstract]   [Full Text] [Related]  

  • 33. [Fully implantable catheter systems for arterial extremity infusion].
    Krawzak HW; Strosche H
    Chirurg; 1989 Jul; 60(7):475-8. PubMed ID: 2791734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of peripheral circulation disorders of lower extremities with Flunarizine and papaverine].
    Brugmans J; Jageneau A; Adriaensen H
    Med Welt; 1977 Jun; 28(23):1056-64. PubMed ID: 886962
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacological preconditioning of ischaemia.
    Laghi Pasini F; Capecchi PL; Acciavatti A; Petri S; de Lalla A; Cati G; Colafati M; Di Perri T
    Clin Hemorheol Microcirc; 1997; 17(1):73-84. PubMed ID: 9181761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic use of flunarizine in the treatment arteriopathies of the lower extremities].
    Ambrosi V; Gabrielli F
    Minerva Med; 1983 Mar; 74(13):685-9. PubMed ID: 6220230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Levodopa in the treatment of arterial insufficiency of the lower limbs. Clinical and rheographic trial.
    Vaccaro E; Solitro A; Barba C
    Arzneimittelforschung; 1973 Dec; 23(12):1793-8. PubMed ID: 4205907
    [No Abstract]   [Full Text] [Related]  

  • 38. [New data on vasoactive drug. Patients with peripheral arterial occlusive disease walk twice as long].
    MMW Fortschr Med; 2002 May; 144(21):54. PubMed ID: 12134429
    [No Abstract]   [Full Text] [Related]  

  • 39. [Peripheral Arterial Occlusive Disease. Modern Therapeutic Principles (author's transl)].
    Hach W; Hach V
    MMW Munch Med Wochenschr; 1982 Mar; 124(10):234-8. PubMed ID: 6806610
    [No Abstract]   [Full Text] [Related]  

  • 40. [Intravenous infusion of Naftidrofuryl in the treatment of arterial diseases of the limbs. Clinical and functional study].
    Schmidt C; Royer RJ; Kissel P
    Therapie; 1974; 29(6):915-23. PubMed ID: 4618388
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.